Minimal Functionalization of Ruthenium Compounds with Enhanced Photoreactivity against Hard-to-Treat Cancer Cells and Resistant Bacteria-Reference-Cited by-同舟云学术

Minimal Functionalization of Ruthenium Compounds with Enhanced Photoreactivity against Hard-to-Treat Cancer Cells and Resistant Bacteria

Published:2024-07-23 Issue:31 Volume:63 Page:14673-14690
ISSN:0020-1669
Container-title:Inorganic Chemistry
language:en
Short-container-title:Inorg. Chem.

Author:

Oliveira Geângela de Fátima Sousa¹,Gouveia Florencio Sousa¹,Andrade Alexandre Lopes²,de Vasconcelos Mayron Alves³^ORCID,Teixeira Edson Holanda²,Palmeira-Mello Marcos V.⁴^ORCID,Batista Alzir A.⁴,Lopes Luiz Gonzaga de França¹^ORCID,de Carvalho Idalina Maria Moreira¹^ORCID,Sousa Eduardo Henrique Silva¹^ORCID

Affiliation:

1. Laboratório de Bioinorgânica, Departmento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Fortaleza 60440-900, Brazil

2. Laboratório Integrado de Biomoléculas, Departamento de Patologia e Medicina Legal, Universidade Federal do Ceará, Fortaleza, Ceará 60441-750, Brazil

3. Faculdade de Educação de Itapipoca, Universidade Estadual do Ceará, Itapipoca, Ceará 62500-000, Brazil

4. Departamento de Química, Universidade Federal de São Carlos, PO Box 676, São Carlos, São Paulo 13565-905, Brazil

Funder

Funda????o Cearense de Apoio ao Desenvolvimento Cient??fico e Tecnol??gico

Minist??rio da Ci??ncia, Tecnologia e Inova????o

Funda????o de Amparo ?? Pesquisa do Estado de S??o Paulo

Coordena????o de Aperfei??oamento de Pessoal de N??vel Superior

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.inorgchem.4c02235

Reference86 articles.

1. The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials

2. Luminescent ruthenium–polypyridine complexes & phosphorus ligands: anything but a simple story

3. Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433

4. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy

5. Metals to combat antimicrobial resistance